Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

NASDAQ:SLAB - Nasdaq - US8269191024 - Common Stock - Currency: USD

155.33  -3.37 (-2.12%)

After market: 155.33 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SLAB. SLAB was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. SLAB has a great financial health rating, but its profitability evaluates not so good. SLAB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLAB has reported negative net income.
SLAB had a negative operating cash flow in the past year.
In multiple years SLAB reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SLAB reported negative operating cash flow in multiple years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of SLAB (-15.62%) is worse than 77.78% of its industry peers.
SLAB's Return On Equity of -17.69% is on the low side compared to the rest of the industry. SLAB is outperformed by 74.07% of its industry peers.
Industry RankSector Rank
ROA -15.62%
ROE -17.69%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

With a decent Gross Margin value of 53.42%, SLAB is doing good in the industry, outperforming 70.37% of the companies in the same industry.
In the last couple of years the Gross Margin of SLAB has declined.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

More info and screens

9

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SLAB has less shares outstanding
There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 23.34 indicates that SLAB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.34, SLAB belongs to the top of the industry, outperforming 89.81% of the companies in the same industry.
There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.34
ROIC/WACCN/A
WACC11.81%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SLAB has a Current Ratio of 6.15. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
SLAB's Current ratio of 6.15 is amongst the best of the industry. SLAB outperforms 86.11% of its industry peers.
SLAB has a Quick Ratio of 5.07. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
SLAB's Quick ratio of 5.07 is amongst the best of the industry. SLAB outperforms 87.04% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 5.07
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

SLAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -208.18%.
Looking at the last year, SLAB shows a very negative growth in Revenue. The Revenue has decreased by -25.30% in the last year.
The Revenue has been growing slightly by 4.28% on average over the past years.
EPS 1Y (TTM)-208.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.76%
Revenue 1Y (TTM)-25.3%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%91.43%

3.2 Future

Based on estimates for the next years, SLAB will show a very strong growth in Earnings Per Share. The EPS will grow by 65.56% on average per year.
Based on estimates for the next years, SLAB will show a very strong growth in Revenue. The Revenue will grow by 22.37% on average per year.
EPS Next Y138.34%
EPS Next 2Y89.25%
EPS Next 3Y65.56%
EPS Next 5YN/A
Revenue Next Year36.42%
Revenue Next 2Y28.49%
Revenue Next 3Y22.37%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLAB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 235.52, which means the current valuation is very expensive for SLAB.
Based on the Price/Forward Earnings ratio, SLAB is valued a bit more expensive than 62.96% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SLAB to the average of the S&P500 Index (22.68), we can say SLAB is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 235.52
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

SLAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as SLAB's earnings are expected to grow with 65.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.25%
EPS Next 3Y65.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILICON LABORATORIES INC

NASDAQ:SLAB (2/21/2025, 8:00:02 PM)

After market: 155.33 0 (0%)

155.33

-3.37 (-2.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners104.06%
Inst Owner Change3.72%
Ins Owners1.77%
Ins Owner Change-0.24%
Market Cap5.04B
Analysts72.22
Price Target145.86 (-6.1%)
Short Float %6.86%
Short Ratio6.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.8%
Min EPS beat(2)-0.51%
Max EPS beat(2)38.1%
EPS beat(4)3
Avg EPS beat(4)14.93%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)4
Avg EPS beat(8)9.5%
EPS beat(12)8
Avg EPS beat(12)16.72%
EPS beat(16)12
Avg EPS beat(16)23.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.56%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.55%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)1.68%
Revenue beat(8)1
Avg Revenue beat(8)-0.74%
Revenue beat(12)4
Avg Revenue beat(12)-0.2%
Revenue beat(16)6
Avg Revenue beat(16)-4.49%
PT rev (1m)13.35%
PT rev (3m)-7.14%
EPS NQ rev (1m)5.93%
EPS NQ rev (3m)-121.18%
EPS NY rev (1m)-44.51%
EPS NY rev (3m)-44.51%
Revenue NQ rev (1m)1.96%
Revenue NQ rev (3m)-17.05%
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 235.52
P/S 8.63
P/FCF N/A
P/OCF N/A
P/B 4.67
P/tB 7.56
EV/EBITDA N/A
EPS(TTM)-1.72
EYN/A
EPS(NY)0.66
Fwd EY0.42%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS18
BVpS33.27
TBVpS20.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.62%
ROE -17.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.42%
FCFM N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.18%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 5.07
Altman-Z 23.34
F-Score3
WACC11.81%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-208.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.76%
EPS Next Y138.34%
EPS Next 2Y89.25%
EPS Next 3Y65.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.3%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%91.43%
Revenue Next Year36.42%
Revenue Next 2Y28.49%
Revenue Next 3Y22.37%
Revenue Next 5YN/A
EBIT growth 1Y-586.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year179.69%
EBIT Next 3Y64.32%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.17%
OCF growth 3YN/A
OCF growth 5YN/A